Introducing human papillomavirus (HPV) vaccination - a challenge for European vaccine advisory committees and public health services

M Pfleiderer

doi:10.2807/ese.13.33.18951-en

Editorials Open Access

Like 0

Download

Introducing human papillomavirus (HPV) vaccination - a challenge for European vaccine advisory committees and public health services
M Pfleiderer¹
View Affiliations Hide Affiliations

Affiliations: ¹ Paul-Ehrlich-Institut, Federal Agency for Sera and Vaccines, Langen, Germany

Correspondence:
M Pfleiderer
pflmi pei.de
View Citation Hide Citation

Citation style for this article: Pfleiderer M. Introducing human papillomavirus (HPV) vaccination - a challenge for European vaccine advisory committees and public health services. Euro Surveill. 2008;13(33):pii=18951. https://doi.org/10.2807/ese.13.33.18951-en Received: 11 Aug 2008

Previous Article
Table of Contents
Next Article

Abstract

The development of efficient human papillomavirus (HPV) vaccines has required long lasting and tremendous research and development efforts by both academia and industry. However, their availability now turns out to be a major challenge for the public health services of many member states within the European Union (EU) and beyond.